| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.4 |